07/10/2025

Echopoint Medical is proud to announce that we have been selected to join the HeartX Cardiovascular Accelerator program — a leading initiative bringing together innovators driving the future of cardiovascular care.

Through this program, Echopoint will benefit from:
• Hospital-based pilot projects and clinical trials, beginning with our first U.S. study at Baptist Health in Little Rock, Arkansas, providing real-world validation of our technology in a leading cardiovascular centre.
• Strategic mentorship and guidance from clinicians, health systems, and industry experts.
• Collaboration with MedAxiom, the premier cardiovascular community within the American College of Cardiology, connecting us to a broad network of hospital systems, physician leaders, and innovation partners across the United States.
• Enhanced visibility and engagement within the global cardiovascular innovation ecosystem.

Participation in HeartX represents an important step in advancing our mission to improve the diagnosis and management of coronary disease. Our iKOr™ microcatheter system delivers FullPhysiology™ coronary measurements that integrate seamlessly into existing cath lab workflows — providing interventional cardiologists with new insights to support precise and personalised care.

We look forward to working closely with HeartX, HealthTech Arkansas, MedAxiom, and Baptist Health as we accelerate the clinical and commercial development of our technology.

Read more about the HeartX Accelerator Program here.